HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals.

Hernández EG, Daza-Mendoza DA, González-Rivas E, Serrano-Vázquez A, Pérez-Juárez H, Uribe-García A, Rostro-Alonso GO, Morán-Silva P, Rojas-Velázquez L, Ximénez García C

Open source

DOI: 10.3389/fimmu.2026.1907153
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1907153,
  title = {HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals.},
  author = {Hernández EG and Daza-Mendoza DA and González-Rivas E and Serrano-Vázquez A and Pérez-Juárez H and Uribe-García A and Rostro-Alonso GO and Morán-Silva P and Rojas-Velázquez L and Ximénez García C},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1907153},
  url = {https://doi.org/10.3389/fimmu.2026.1907153}
}

RIS

TY  - JOUR
TI  - HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals.
AU  - Hernández EG
AU  - Daza-Mendoza DA
AU  - González-Rivas E
AU  - Serrano-Vázquez A
AU  - Pérez-Juárez H
AU  - Uribe-García A
AU  - Rostro-Alonso GO
AU  - Morán-Silva P
AU  - Rojas-Velázquez L
AU  - Ximénez García C
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1907153
UR  - https://doi.org/10.3389/fimmu.2026.1907153
ER  -

APA

EG, H., DA, D., E, G., A, S., H, P., A, U., GO, R., P, M., L, R., & C, X. G. (2026). HLA-DRB1*14 is associated with lower odds of symptomatic SARS-CoV-2 infection in Mexican individuals.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1907153

Source records

pubmed · retrieved 2026-09-25T17:47:30.842Z